Laura Arnold, Richard Kinder, and more pump $20M into Houston nonprofit news outlet

some good news

Laura Arnold (pictured with husband John) is a big backer of the project. ArnoldVentures.com

Houston will soon have a new source for independent and community-minded journalism, thanks to a $20 million infusion by a group of local nonprofits.

Houston Endowment, the Kinder Foundation, and Arnold Ventures announced the launch of an independent Houston nonprofit news operation in Houston that promises to be one of the largest in the country, according to a press release.

The operation is slated to launch in late 2022 or early 2023 on multiple platforms, the new nonprofit news organization will “elevate the voices of Houstonians and address the needs of the community” as identified in the American Journalism Project’s extensive research.

Specifically, this project was cultivated after a two-year research effort, led by the American Journalism Project. The organization relied on focus groups, community listening sessions, and surveys conducted in four different languages, as well as content analyses of existing coverage to examine local information gaps and news needs.

Notably, this new operation will be free to readers as well as other news organizations. Name, news coverage strategies, and office location will be determined by its new leadership, the announcement notes.

The organization is described as being charged with striving to be the center of conversation about Houston’s critical issues, bridge communities, and foster community engagement while building a vibrant and active following, a release adds.

An introductory web page at localnewsforhouston.org has been created; currently applications for CEO and editor-in-chief are being accepted there.

A search committee for staffing includes:

  • Ann Stern, President & CEO, Houston Endowment
  • Dr. Anne Chao, Manager of the Houston Asian American Archive, Rice University
  • Armando Perez, Executive Vice President, H-E-B Houston, chairman, United Way Greater Houston
  • Jeff Cohen, Executive Vice President, Arnold Ventures
  • Reginald DesRosches, Howard R. Hughes Provost and President-Elect, Rice University
  • Rich Kinder, chairman, Kinder Foundation, and Executive Chairman, Kinder Morgan Inc.

“Commercial news organizations across the United States have rapidly declined in recent years, a trend that directly undermines the foundations of American democracy,” said Laura Arnold, co-founder and co-chair of Arnold Ventures, in a statement. “A free press is essential, and until the industry finds its footing, philanthropy must do its part to help strengthen and safeguard the Fourth Estate. We have long invested in nonprofit journalism, and we are honored to support the establishment of a robust newsroom endeavor in our hometown.”

------

This article originally ran on CultureMap.

The funds will go toward the Kinder Institute's civic data initiatives. Photo via news.rice.edu

Kinder Institute expands its urban data initiatives following $2.25M of fresh funds from the Houston Endowment

Money moves

The Houston Endowment has renewed its support of Rice University's Kinder Institute for Urban Research with a $2.25 million three-year grant to expand its services relating to urban data collection and use.

"We are immensely grateful to Houston Endowment for its continued support of Rice and the Kinder Institute," Rice President David Leebron says in a release. "This renewed funding will allow the institute to continue its critical data-driven work to better understand the challenges that Houston and other cities are facing and create lasting solutions. Contributing to our home city and others in this way is central to Rice's mission and its strategic plan, and we are extremely appreciative of this generous support."

In addition to supporting the Kinder Institute's data tools, the funding will contribute to the Houston Urban Data Project 2.0. The institute is involved in the project as is the Houston Community Data Connections, or HCDC. According to the release, the UDP will work to align and enhance urban and community data initiatives, develop training and research support for a larger user base, and raise awareness of the institute's research through outreach.

The HCDC, which was established in September of 2017, is already equipped to analyze 143 areas in Harris County with over 9,000 users, almost 16,000 site sessions, and over 45,000 page views, per the release. The program has seen 120 research and data requests since launch. Meanwhile, the UDP has 200 datasets in Houston and has 400 users who have accessed the site 6,000 times since it launched in the Spring of 2018

"The UDP and HCDC have laid the foundation for a shift in how data is used and decisions are made in the public, philanthropic and nonprofit sectors, and this funding will allow the Kinder Institute to build on this work," says Bill Fulton, director of the institute, in the release. "This project will help drive effective, data-driven decision-making for the region and will make the Kinder Institute the data hub for the entire region and a model for other cities around the world."

The purpose of the program will be two initiatives: Building Better Cities, which will focus on government efficiency and urban systems, and Building Better Lives, geared at quality of life and urban disparity among Houston residents.

"At Houston Endowment, our vision is a vibrant region where all have the opportunity to thrive," says Ann B. Stern, president and CEO of Houston Endowment, in the release. "We believe that making good data available to the public leads to better-informed decision-making on the part of our public officials and allows residents to more effectively advocate for their communities' needs. This is why the UDP and HCDC are so important for the future of our region."

The Kinder Institute, founded in 2010, is a research and advocate organization for urban development in Houston, and the Houston Endowment, established by Jesse H. and Mary Gibbs Jones in 1937, has assets of $1.8 billion and contributes around $70 million annually.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

5 must-read innovation headlines: Pharma giant considers Houston hub + more

Trending news

Editor's note: With May coming to a close, it's time to look back at the biggest innovation headlines for the second half of the month. Major moves were made in May, with NuScale Power entering the market, Persona AI inking a deal with Under Armour, and a pharma giant considering Houston for its next manufacturing hub. Here are the most-read InnovationMap stories published May 15-29, 2026:

1. Pharma giant considers Houston for $1 billion manufacturing campus

Another pharmaceutical giant is considering Houston’s Generation Park for a manufacturing hub. According to a recent filing with the Texas Jobs, Energy, Technology and Innovation (JETI) program, Bristol Myers Squibb Co. is considering the northeast Houston management district for a new $1 billion multi-modal pharmaceutical manufacturing campus.

2. Modular nuclear reactor co. NuScale Power moves into Houston market

The nuclear energy renaissance continues in Texas with an announcement by NuScale Power. The Oregon-based provider of proprietary and innovative advanced small modular reactor (SMR) nuclear technology announced in April it would be opening office space in Houston’s CityCentre.

3. Persona AI teams with Under Armour to protect next-gen robots

Houston-based Persona AI has cemented a partnership with sportswear manufacturer Under Armour to provide materials to protect future robots operating in dangerous conditions. Through the partnership, Persona AI and Under Armour will launch a research initiative to explore whether advanced performance textiles can improve the durability and resilience of humanoid robots operating in harsh industrial environments.

4. Houston quantum energy chip startup emerges from stealth with $12M round

Houston-based Casimir has emerged from stealth with a $12 million seed round to commercialize its quantum energy chip. The round was led by Austin-based Scout Ventures. Lavrock Ventures, Cottonwood Technology, Capital Factory, American Deep Tech, and Tim Draper of Draper Associates also participated in the round. The oversubscribed round exceeded the company’s original $8 million target.

5. Global summit spotlights Houston's growing role in brain health, innovation

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. The summit, held June 9-10 at the Texas Medical Center's Helix Park, will bring together more than 500 executives, researchers, policymakers and innovators from around the world to discuss the global brain economy.

View All Listings